Market Research Logo

Metanomics Health GmbH - Product Pipeline Analysis, 2018 Update

Summary

Metanomics Health GmbH (Metanomics), a subsidiary of BASF SE, is a biotech company that provides metabolic biomarker identification and validation solutions. The company offers analysis of metabolites for various applications in pharma and biotech, biobanking, academia, food and feed industry and diagnostics fields. It develops novel biomarkers for early asymptomatic heart failure and type-2 diabetes. The company’s products include MxP global profiling, MxP targeted profiling, MxP isotope tracer, MxP catecholamines and steroids, MxP biofluids quality control and diagnostic type assays. It conducts biomarker program, which include development of new diagnostic metabolic biomarkers; co-development of companion diagnostic biomarkers; development of metabolic biomarkers; and identification and validation of new drug targets. The company operates in Japan and the US. Metanomics is headquartered in Berlin, Germany.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Metanomics Health GmbH
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


Metanomics Health GmbH Company Overview
Metanomics Health GmbH Company Snapshot 4
Metanomics Health GmbH Pipeline Products and Ongoing Clinical Trials Overview
Metanomics Health GmbH – Pipeline Analysis Overview 6
Metanomics Health GmbH - Key Facts 6
Metanomics Health GmbH - Major Products and Services 7
Metanomics Health GmbH Pipeline Products by Development Stage 8
Metanomics Health GmbH Pipeline Products Overview 10
Diagnostic Assay - Multiple Sclerosis 10
Diagnostic Assay - Multiple Sclerosis Product Overview 10
Diagnostic Assay - Pancreatic Cancer 11
Diagnostic Assay - Pancreatic Cancer Product Overview 11
Diagnostic Assay - NSCLC 12
Diagnostic Assay - NSCLC Product Overview 12
Diagnostic Assay - Congestive Heart Failure 13
Diagnostic Assay - Congestive Heart Failure Product Overview 13
Diagnostic Assay - Non-Alcoholic Steatohepatitis 14
Diagnostic Assay - Non-Alcoholic Steatohepatitis Product Overview 14
Diagnostic Assay - Type 2 Diabetes 15
Diagnostic Assay - Type 2 Diabetes Product Overview 15
Diagnostic Assay - Type 2 Diabetes Risk 16
Diagnostic Assay - Type 2 Diabetes Risk Product Overview 16
Prognostic Assay - Prostate Cancer 17
Prognostic Assay - Prostate Cancer Product Overview 17
Prognostic Assay - Congestive Heart Failure 18
Prognostic Assay - Congestive Heart Failure Product Overview 18
Metanomics Health GmbH - Key Competitors 19
Metanomics Health GmbH - Key Employees 20
Metanomics Health GmbH - Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 22
Metanomics Health GmbH, Recent Developments 22
Jun 03, 2016: BASF Hires PwC to Explore Strategic Options For Metanomics Health 22
Aug 26, 2014: Cenix BioScience and Metanomics Health sign research agreement 22
Appendix 23
Methodology 23
About GlobalData 26
Contact Us 26
Disclaimer 26
List of Tables
Metanomics Health GmbH Pipeline Products and Ongoing Clinical Trials Overview 4
Metanomics Health GmbH Pipeline Products by Equipment Type 5
Metanomics Health GmbH Pipeline Products by Indication 5
Metanomics Health GmbH, Key Facts 6
Metanomics Health GmbH, Major Products and Services 7
Metanomics Health GmbH Number of Pipeline Products by Development Stage 8
Metanomics Health GmbH Pipeline Products Summary by Development Stage 9
Diagnostic Assay - Multiple Sclerosis - Product Status 10
Diagnostic Assay - Multiple Sclerosis - Product Description 10
Diagnostic Assay - Pancreatic Cancer - Product Status 11
Diagnostic Assay - Pancreatic Cancer - Product Description 11
Diagnostic Assay - NSCLC - Product Status 12
Diagnostic Assay - NSCLC - Product Description 12
Diagnostic Assay - Congestive Heart Failure - Product Status 13
Diagnostic Assay - Congestive Heart Failure - Product Description 13
Diagnostic Assay - Non-Alcoholic Steatohepatitis - Product Status 14
Diagnostic Assay - Non-Alcoholic Steatohepatitis - Product Description 14
Diagnostic Assay - Type 2 Diabetes - Product Status 15
Diagnostic Assay - Type 2 Diabetes - Product Description 15
Diagnostic Assay - Type 2 Diabetes Risk - Product Status 16
Diagnostic Assay - Type 2 Diabetes Risk - Product Description 16
Prognostic Assay - Prostate Cancer - Product Status 17
Prognostic Assay - Prostate Cancer - Product Description 17
Prognostic Assay - Congestive Heart Failure - Product Status 18
Prognostic Assay - Congestive Heart Failure - Product Description 18
Metanomics Health GmbH, Key Employees 20
Metanomics Health GmbH, Other Locations 21
Glossary 25
List of Figures
Metanomics Health GmbH Pipeline Products by Equipment Type 5
Metanomics Health GmbH Pipeline Products by Development Stage 8

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report